IL123791A0 - Transgenic animals for xenotransplantation with reduced antibody-mediated rejection - Google Patents

Transgenic animals for xenotransplantation with reduced antibody-mediated rejection

Info

Publication number
IL123791A0
IL123791A0 IL12379196A IL12379196A IL123791A0 IL 123791 A0 IL123791 A0 IL 123791A0 IL 12379196 A IL12379196 A IL 12379196A IL 12379196 A IL12379196 A IL 12379196A IL 123791 A0 IL123791 A0 IL 123791A0
Authority
IL
Israel
Prior art keywords
xenotransplantation
transgenic animals
reduced antibody
mediated rejection
rejection
Prior art date
Application number
IL12379196A
Other languages
English (en)
Original Assignee
Nextran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nextran filed Critical Nextran
Publication of IL123791A0 publication Critical patent/IL123791A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL12379196A 1995-09-27 1996-09-23 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection IL123791A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US446195P 1995-09-27 1995-09-27
US08/675,773 US6166288A (en) 1995-09-27 1996-07-03 Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
PCT/US1996/015255 WO1997012035A2 (fr) 1995-09-27 1996-09-23 Animaux transgeniques pour xenotransplantation avec limitation du rejet induit par des anticorps

Publications (1)

Publication Number Publication Date
IL123791A0 true IL123791A0 (en) 1998-10-30

Family

ID=26673032

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12379196A IL123791A0 (en) 1995-09-27 1996-09-23 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection

Country Status (10)

Country Link
US (1) US6166288A (fr)
EP (1) EP0853665A2 (fr)
JP (1) JP2001517924A (fr)
CN (1) CN1278299A (fr)
AU (1) AU727546B2 (fr)
BR (1) BR9610843A (fr)
CA (1) CA2233040A1 (fr)
IL (1) IL123791A0 (fr)
MX (1) MXPA98002434A (fr)
WO (1) WO1997012035A2 (fr)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331658B1 (en) * 1993-04-20 2001-12-18 Integris Baptist Medical Center, Inc. Genetically engineered mammals for use as organ donors
US6231608B1 (en) * 1995-06-07 2001-05-15 Crosscart, Inc. Aldehyde and glycosidase-treated soft and bone tissue xenografts
EP0940467B1 (fr) * 1996-05-17 2005-12-28 Nippon Meat Packers, Inc. Promoteurs d'inhibiteurs complementaires porcins
US6455037B1 (en) * 1996-11-01 2002-09-24 Mount Sinai School Of Medicine Of The City University Of New York Cells expressing an αgala nucleic acid and methods of xenotransplantation
US6011197A (en) 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
WO1999003336A1 (fr) 1997-07-14 1999-01-28 Nippon Meat Packers, Inc. Mammiferes transgeniques
CA2248971A1 (fr) * 1997-10-31 1999-04-30 Kyowa Hakko Kogyo Co., Ltd. Beta-1,3-n-acetylglucosaminyltransferase, adn l'encodant et son utilisation
US6383732B1 (en) * 1999-02-11 2002-05-07 Crosscart, Inc. Method of preparing xenograft heart valves
GB9807520D0 (en) 1998-04-09 1998-06-10 Univ Wales Medicine Modified biological material
US6197294B1 (en) 1998-10-26 2001-03-06 Neurotech S.A. Cell surface molecule-induced macrophage activation
US6258998B1 (en) 1998-11-24 2001-07-10 Infigen, Inc. Method of cloning porcine animals
US6700037B2 (en) 1998-11-24 2004-03-02 Infigen, Inc. Method of cloning porcine animals
US6267786B1 (en) * 1999-02-11 2001-07-31 Crosscart, Inc. Proteoglycan-reduced soft tissue xenografts
JP4551041B2 (ja) * 1999-06-29 2010-09-22 協和発酵キリン株式会社 有用ポリペプチド
US7820878B2 (en) 1999-11-19 2010-10-26 Kyowa Hakko Kirin Co., Ltd. Production of ungulates, preferably bovines that produce human immunoglobulins
US7414170B2 (en) 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
US7074983B2 (en) 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
AU2001261650A1 (en) * 2000-05-15 2001-11-26 Geron Corporation Ovine tissue for xenotransplantation
WO2002015681A1 (fr) * 2000-08-25 2002-02-28 Nippon Meat Packers, Inc. Mammiferes transgeniques
DK1572862T3 (da) * 2001-02-20 2012-11-26 Intrexon Corp Kimære, retinoide x-receptorer og deres anvendelse i et hidtil ukendt ecdysonrecepttorbaseret inducerbart genekspressionssystem
US7126039B2 (en) 2001-03-21 2006-10-24 Geron Corporation Animal tissue with carbohydrate antigens compatible for human transplantation
US7166278B2 (en) * 2001-04-30 2007-01-23 Rbc Biotechnology, Inc. Modified organs and cells for xenotransplantation
US20050108780A1 (en) * 2002-01-24 2005-05-19 Erasmus University Intracellular antibodies for a retrovirus protein
EP1534066A4 (fr) 2002-08-14 2008-01-02 Immerge Biotherapeutics Inc Cellules depourvues d'alpha(1,3)-galactosyltransferase, procedes de selection et porc depourvu d'alpha(1,3)-galactosyltransferase ainsi obtenu
US7429690B2 (en) 2002-11-08 2008-09-30 Kirin Holdings Kabushiki Kaisha Transgenic bovines having reduced prion protein production
US7514593B2 (en) 2003-05-30 2009-04-07 The University Of North Carolina At Chapel Hill Animal model for chronic obstructive pulmonary disease and cystic fibrosis
JP2007525955A (ja) * 2003-06-06 2007-09-13 ユニバーシティー オブ ピッツバーグ ブタｃｍｐ−ｎ−アセチルノイラミン酸ヒドロキシラーゼ遺伝子
EP3184629A1 (fr) 2003-06-20 2017-06-28 Axiogenesis Ag Découverte de médicaments à base de tissu produit in vitro
US20050028228A1 (en) 2003-07-21 2005-02-03 Lifecell Corporation Acellular tissue matrices made from alpa-1,3-galactose-deficient tissue
WO2005104835A2 (fr) 2004-04-22 2005-11-10 Kirin Beer Kabushiki Kaisha Animaux transgeniques et leurs utilisations
WO2005111204A2 (fr) * 2004-05-07 2005-11-24 University Of Pittsburgh Of The Commonwealth System Of Higher Education Protéine de ligase de forssman porcine, adn complémentaire, organisation génomique et région de réglementation
ATE490306T1 (de) 2004-05-11 2010-12-15 Axiogenesis Ag Methoden zur medikamentenaufspürung auf der basis von in vitro differenzierten zellen
CA3079874C (fr) 2004-10-22 2023-01-03 Revivicor, Inc. Ongules dotes de systemes immunitaires genetiquement modifies
NZ565711A (en) * 2005-08-09 2011-10-28 Revivicor Inc Transgenic ungulates expressing a porcine CTLA4 peptide fused to an immunoglobulin
JP5244093B2 (ja) 2006-05-09 2013-07-24 ライフセル コーポレーション 強化型生体組織
US7663019B2 (en) * 2006-05-24 2010-02-16 North Carolina State University Transgenic snakes and methods of making
US8124831B2 (en) * 2006-07-06 2012-02-28 Duke University Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase
AU2008275072B2 (en) 2007-07-10 2013-03-14 Lifecell Corporation Acellular tissue matrix compositions for tissue repair
KR101149475B1 (ko) 2007-11-30 2012-05-25 한국생명공학연구원 이종 장기 이식용 미니 복제돼지 생산을 위한 유전자 조작된 세포주 및 그의 생산방법
US9259511B2 (en) 2008-06-06 2016-02-16 Lifecell Corporation Elastase treatment of tissue matrices
WO2010051288A1 (fr) 2008-10-27 2010-05-06 Revivicor, Inc. Ongulés immunodéprimés
EP2349089A4 (fr) 2008-11-21 2014-01-15 Lifecell Corp Matériau biologique renforcé
US8986377B2 (en) 2009-07-21 2015-03-24 Lifecell Corporation Graft materials for surgical breast procedures
CA2769188C (fr) * 2009-09-02 2019-02-12 Lifecell Corporation Greffes vasculaires issues de matrices de tissus acellulaires
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
US20110135706A1 (en) * 2009-12-03 2011-06-09 Lifecell Corporation Nerve treatment devices and methods
CA2786228C (fr) 2010-02-19 2018-02-06 Lifecell Corporation Dispositifs servant a traiter la paroi abdominale
EP2550028B1 (fr) 2010-03-25 2018-03-07 Lifecell Corporation Préparation de supports de tissus se régénérant
CA3054722A1 (fr) 2010-07-08 2012-01-12 Lifecell Corporation Procede de formation de matrices de tissu
US20120040013A1 (en) 2010-08-10 2012-02-16 LifeCell Corporation. Regenerative Tissue Scaffolds
JP5930415B2 (ja) 2010-08-26 2016-06-08 ライフセル コーポレーションＬｉｆｅＣｅｌｌ Ｃｏｒｐｏｒａｔｉｏｎ 抗菌生物学的メッシュのための受動的方法
WO2012078968A2 (fr) 2010-12-10 2012-06-14 Lifeline Scientific, Inc. Perfusion assistée par machine, par des inhibiteurs du complément
NZ759163A (en) * 2011-02-14 2023-03-31 Revivicor Inc Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
US8637067B1 (en) 2011-03-10 2014-01-28 Lifecell Corporation Elastic tissue matrix derived hydrogel
BR112013026200A2 (pt) 2011-04-14 2019-08-27 Lifecell Corp método para preparar uma composição de matriz de tecido, e matriz de tecido
US10207025B2 (en) 2011-04-28 2019-02-19 Lifecell Corporation Method for enzymatic treatment of tissue products
US9238793B2 (en) 2011-04-28 2016-01-19 Lifecell Corporation Method for enzymatic treatment of tissue products
ES2720137T3 (es) 2011-04-28 2019-07-18 Lifecell Corp Método para el tratamiento enzimático de productos tisular
ES2784156T3 (es) 2011-11-10 2020-09-22 Lifecell Corp Método para la eliminación del espacio a través de la aproximación de tejidos
CA2854885C (fr) 2011-11-10 2020-08-25 Lifecell Corporation Dispositif pour le traitement d'un tendon et d'un ligament
EP2793964B1 (fr) 2011-12-20 2019-03-20 LifeCell Corporation Produits de tissu en feuille
ES2726105T3 (es) 2011-12-20 2019-10-01 Lifecell Corp Productos de tejido fluidizable
DK2806907T3 (en) 2012-01-24 2019-02-18 Lifecell Corp EXTENDED TISSUE MATRIX
ES2716993T3 (es) 2012-03-08 2019-06-18 Lifecell Corp Matrices de colágeno y tejido activadas por enzimas
US9782436B2 (en) 2012-04-24 2017-10-10 Lifecell Corporation Flowable tissue matrices
US9999637B2 (en) 2012-04-24 2018-06-19 Lifecell Corporation Functionalized tissue matrices
EP2869861B1 (fr) 2012-07-05 2018-04-11 Lifecell Corporation Collecteurs de drains à base de tissu
DK2869858T3 (da) 2012-07-06 2019-05-13 Lifecell Corp Decellulariseret muskelmatrix
BR112015006393A2 (pt) 2012-09-26 2017-07-04 Lifecell Corp método para produzir um produto de tecido, produto de tecido produzido por um processo, e método de tratamento
US20140115728A1 (en) 2012-10-24 2014-04-24 A. Joseph Tector Double knockout (gt/cmah-ko) pigs, organs and tissues
US9592254B2 (en) 2013-02-06 2017-03-14 Lifecell Corporation Methods for localized modification of tissue products
CN103284797B (zh) * 2013-05-30 2016-06-29 美合实业（苏州）有限公司 一种内置消毒清洗装置的全科诊疗仪
WO2015035115A1 (fr) 2013-09-05 2015-03-12 Lifecell Corporation Procédés de traitement enzymatique de produits tissulaires
EP3065790B1 (fr) 2013-11-04 2020-10-28 LifeCell Corporation Procédé d'élimination d'alpha-galactose
CA3225091A1 (fr) 2014-05-05 2015-11-12 Regeneron Pharmaceuticals, Inc. Animaux porteurs des sequences c5 et c3 humanisees
WO2016025666A1 (fr) 2014-08-14 2016-02-18 Lifecell Corporation Matrices tissulaires et méthodes de traitement
EP3220925B1 (fr) 2014-10-22 2022-03-16 Indiana University Research & Technology Corporation Porcs triples transgéniques appropriés pour la xénogreffe
US10850008B2 (en) 2015-12-11 2020-12-01 Lifecell Corporation Methods and systems for stiffening of tissue for improved processing
US11179505B2 (en) 2016-02-11 2021-11-23 Lifecell Corporation Methods for stabilizing collagen-containing tissue products against enzymatic degradation
WO2017210109A1 (fr) 2016-06-03 2017-12-07 Lifecell Corporation Procédés de modification localisée de produits tissulaires
US10639398B2 (en) 2016-07-05 2020-05-05 Lifecell Corporation Tissue matrices incorporating multiple tissue types
WO2018118944A1 (fr) 2016-12-22 2018-06-28 Lifecell Corporation Dispositifs et procédés de cryobroyage de tissu
CA3047816A1 (fr) 2016-12-23 2018-06-28 Lifecell Corporation Polyurethanes injectables et leurs applications
WO2018118862A1 (fr) 2016-12-23 2018-06-28 Lifecell Corporation Hydrogels injectables et leurs applications
AU2018212908A1 (en) 2017-01-30 2019-08-08 Lifecell Corporation Transglutaminase treated products
CA3050733A1 (fr) 2017-01-30 2018-08-02 Lifecell Corporation Dispositifs comprenant une matrice musculaire et procedes de production et d'utilisation
CN110430903B (zh) 2017-01-30 2022-08-19 生命细胞公司 组织基质材料和酶粘合剂
CN107099513B (zh) * 2017-06-22 2020-07-14 北京邦卓生物科技有限公司 一种共表达ndv hn和ibdv vp2基因的hvt的构建及其应用
CN114127560A (zh) * 2019-03-21 2022-03-01 Uab研究基金会 增加细胞对补体介导裂解的敏感性的方法
WO2021091539A1 (fr) 2019-11-05 2021-05-14 Versiti Blood Research Institute Foundation, Inc. Modèle murin de thrombocytopénie allo-immune fœtale/néonatale
US11266129B2 (en) 2019-11-05 2022-03-08 Versiti Blood Research Institute Foundation, Inc. Murine model of fetal/neonatal alloimmune thrombocytopenia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
IL95970A0 (en) * 1989-10-12 1992-05-25 Imutran Ltd Use of homologous complement restriction factors in preventing xenograft rejection
US5324663A (en) * 1990-02-14 1994-06-28 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
DE69233010T2 (de) * 1991-07-15 2004-02-19 Oklahoma Medical Research Foundation, Oklahoma Universale spenderzellen
JPH08501451A (ja) * 1992-09-22 1996-02-20 ディーエヌエックス バイオセラピューティックス、インコーポレーテッド 異種移植臓器移植片の事前適応化、その他を目的とする膜間転移によるタンパク質の供給法
WO1994017822A1 (fr) * 1993-02-12 1994-08-18 T Cell Sciences, Inc. ADMINISTRATION PULMONAIRE DE RECEPTEUR DE COMPLEMENT SOLUBLE sCR1 ET D'AUTRES PROTEINES D'INHIBITION DU COMPLEMENT
US5750176A (en) * 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
JPH10504442A (ja) * 1994-04-13 1998-05-06 バイオトランスプラント，インコーポレイテッド α（１，３）ガラクトシルトランスフェラーゼ陰性ブタ
WO1995034202A1 (fr) * 1994-06-15 1995-12-21 Alexion Pharmaceuticals, Inc. Procedes permettant de reduire le rejet suraigu d'heterogreffes
AUPM772494A0 (en) * 1994-08-30 1994-09-22 Austin Research Institute, The Improvements in production of proteins in host cells
GB9421464D0 (en) * 1994-10-25 1994-12-07 Imutran Ltd Recombinant DNA

Also Published As

Publication number Publication date
US6166288A (en) 2000-12-26
MXPA98002434A (es) 2005-04-29
WO1997012035A2 (fr) 1997-04-03
WO1997012035A3 (fr) 1997-06-12
CN1278299A (zh) 2000-12-27
CA2233040A1 (fr) 1997-04-03
EP0853665A2 (fr) 1998-07-22
JP2001517924A (ja) 2001-10-09
BR9610843A (pt) 1999-07-13
AU7117096A (en) 1997-04-17
AU727546B2 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
IL123791A0 (en) Transgenic animals for xenotransplantation with reduced antibody-mediated rejection
EP0630558A3 (fr) Dispositif de traite automatique d'animaux.
EP1015556A4 (fr) Plantes transgeniques a l'epreuve des agressions du milieu
IL107062A0 (en) Transgenic animal models for neurodegenerative disease
EP0630557A3 (fr) Dispositif de traite automatique d'animaux.
GB9621113D0 (en) Transgenic fish
EP0635203A3 (fr) Dispositif de traite automatique d'animaux.
GB9716154D0 (en) Trough for animals
DE69533440D1 (de) Automatische zuführvorrichtung
EP0867114A4 (fr) Obtention d'un animal transgenique
GB9408428D0 (en) Automatic animal feeder
GB9610285D0 (en) Transgenic plants
GB9522729D0 (en) Automatic poultry weigher
GB2305348B (en) Animal litter tray
GB9503868D0 (en) Transgenic animals
EP0724828A3 (fr) Conteneur d'élevage d'animaux
GB9709740D0 (en) Automatic milking
KR950031841U (ko) 수족관의 먹이 자동공급장치
GB9624685D0 (en) Transgenic plants
GB9402882D0 (en) Automatic animal feeder
HRP940246A2 (en) Automatic watering device for animals
GB9605581D0 (en) Automatic animal feeder
AU8505998A (en) Transgenic transmitochondrial animals
KR960028896U (ko) 릴 형태의 제품 자동 공급 장치
ZA96637B (en) Automatic pet feeder